Medical treatment of endocrine gastroenteropancreatic tumors.
Tomassetti
Paola
P
Department of Internal Medicine, Sant'Orsola-Malpighi Hospital, Bologna, Italy. paola.tomassetti@unibo.it
Campana
Davide
D
Nori
Francesca
F
Piscitelli
Lidya
L
Salomone
Luisa
L
Pezzilli
Raffaele
R
Corinaldesi
Roberto
R
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016461:Chemoembolization, Therapeutic; D003131:Combined Modality Therapy; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D009378:Neoplasms, Multiple Primary / Q000175:diagnosis / Q000601:surgery / Q000628:therapy*; D018358:Neuroendocrine Tumors / Q000175:diagnosis / Q000601:surgery / Q000628:therapy*; D015282:Octreotide / Q000627:therapeutic use; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000601:surgery / Q000628:therapy*; D016499:Radioimmunotherapy; D013004:Somatostatin / Q000627:therapeutic use; D013274:Stomach Neoplasms / Q000175:diagnosis / Q000601:surgery / Q000628:therapy*
D018931:Antineoplastic Agents, Hormonal; D016898:Interferon-alpha; D013004:Somatostatin; D015282:Octreotide